Merck KGaA
DB:MRK
Germany / Healthcare / Pharmaceuticals
Exchange Data
Hide this widget
Price
127.70 EUR
Day change
-3.95 (-3.00%)
52-week range
127.65 - 176.50
10:15 - Delayed Data
Summary of Merck KGaA
Hide this widget
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The compan...
Price History
Chart Gallery
Hide this widget
1 Week
1 Month
3 Months
1 Year
5 Year
10 Years
- (-)
Data Explorer
Hide this widget
Data could not be retrieved
Peer Benchmarks
Hide this widget
Quote
Value
Size
Growth
Profit
| MRK | Peers | Sector | |
|---|---|---|---|
Market Cap | 56.869 B | 8.405 B | 61.02 M |
Price % of 52 Week High | Premium | 72.2% | 62.6% |
Dividend Yield | 1.7% | 1.7% | 0.0% |
Shareholder Yield | Premium | 1.9% | -0.7% |
1 Year Price Total Return | -16.2% | -5.1% | -11.3% |
Beta (5 Year) | 0.74 | 0.54 | 0.64 |
In the News
Hide this widget
Fair Value
Hide this widget
Average
–
Upside
–
Uncertainty
–
Spread
–
Financial Health
Health Details
Hide this widget
Financial Health for Merck KGaA is determined by ranking the company on over 100 factors against companies in the Healthcare sector and operating in Developed economic markets.
12345
Financial Models for Merck KGaA
Model Gallery
Hide this widget
| 10Y DCF EBITDA ExitView Updated 12 hours ago |
| 10Y DCF Revenue ExitView Updated 12 hours ago |
| 10Y DCF Growth ExitView Updated 12 hours ago |
| 5Y DCF EBITDA ExitView Updated 12 hours ago |
| 5Y DCF Revenue ExitView Updated 12 hours ago |
| 5Y DCF Growth ExitView Updated 12 hours ago |
| DDM Stable GrowthView Updated 12 hours ago |
| DuPont ROE AnalysisView Updated 4 days ago |
| Earnings Power ValueView Updated 12 hours ago |
| 10Y Historical FinancialsView Updated 4 days ago |
| 5Y Historical FinancialsView Updated 4 days ago |
| EV / EBIT MultiplesView Updated 12 hours ago |
| EV / EBITDA MultiplesView Updated 12 hours ago |
| P/E MultiplesView Updated 12 hours ago |
| Price / Book MultiplesView Updated 12 hours ago |
| Price / Sales MultiplesView Updated 12 hours ago |
| EV / Revenue MultiplesView Updated 12 hours ago |
| CAPM WACC ModelView Updated 17 hours ago |
| DDM Multi StageView Updated 12 hours ago |
Historical Financials
Full Financials
Hide this widget
| (EUR in millions) | Trailing Twelve Months | Fiscal Quarters | |||
|---|---|---|---|---|---|
| Period Ending | Dec-22 | Dec-23 | Dec-24 | Dec-23 | Dec-24 |
| Income Statement | |||||
| Revenue | 22,232 | 20,993 | 21,156 | 5,225 | 5,418 |
| Operating Income | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Net Profit | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Diluted EPS | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| EBITDA | |||||
| Balance Sheet | |||||
| Cash & ST Invest. | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Assets | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Current Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Liabilities | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Equity | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Total Debt | 10,428 | 9,941 | 10,301 | 9,941 | 10,301 |
| Cash Flow Statement | |||||
| Cash Flow Operations | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Investing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Cash From Financing | InvPro+ | InvPro+ | InvPro+ | InvPro+ | InvPro+ |
| Free Cash Flow | 2,728 | 1,977 | 2,884 | 542 | 823 |
Analyst Notes
March 26, 2025
Hide this widget